XML 75 R41.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Taxes [Abstract]  
Schedule of Company’s Loss Before Income Taxes

The Company’s loss before income taxes includes the following components:

 

   Years Ended December 31, 
   2024   2023 
United States loss before income taxes  $7,639,148   $15,928,780 
China loss before income taxes   264,246    778,230 
Total loss before income taxes  $7,903,394   $16,707,010 
Schedule of Components of Income Taxes Expense (Benefit)

Components of income taxes expense (benefit) consisted of the following:

 

   Years Ended December 31, 
   2024   2023 
Current:        
U.S. federal  $
-
   $
-
 
U.S. state and local   
-
    
-
 
China   
-
    
-
 
Total current income taxes expense  $
-
   $
-
 
Deferred:          
U.S. federal  $(4,874)  $(3,256,007)
U.S. state and local   (1,650)   (1,102,392)
China   93,437    (183,443)
Total deferred income taxes (benefit)  $86,913   $(4,541,842)
Change in valuation allowance   (86,913)   4,541,842 
Total income taxes expense  $
-
   $
-
 
Schedule of U.S. Statutory Rate and the Company’s Effective Tax Rate

The table below summarizes the differences between the U.S. statutory rate and the Company’s effective tax rate for the years ended December 31, 2024 and 2023:

 

   Years Ended December 31, 
   2024   2023 
U.S. federal rate   21.0%   21.0%
U.S. state rate   6.4%   6.7%
Permanent difference   (1.3)%   (0.1)%
Non-US rate differential   0.1%   0.2%
True ups   (27.3)%   (0.6)%
U.S. valuation allowance   1.1%   (27.2)%
Total provision for income taxes   0.0%   0.0%
Schedule of Deferred Taxes

The Company’s components of deferred taxes as of December 31, 2024 and 2023 were as follows:

 

   December 31,
2024
   December 31,
2023
 
Deferred tax assets        
Stock-based compensation  $1,598,257   $3,501,507 
Disallowed business interest deduction   
-
    9,476 
Research and development expense   106,783    130,823 
Accrued directors’ compensation   104,977    165,490 
Accrued settlement   140,904    126,496 
Partnership Investment   2,167,965    2,422,744 
Lease liability   1,687    20,935 
Capital loss limitation   149,394    149,394 
Net operating loss carryforward   17,648,077    15,493,570 
Total deferred tax assets, gross   21,918,044    22,020,435 
Valuation allowance   (21,784,638)   (21,871,551)
Total deferred tax assets, net  $133,406   $148,884 
Deferred tax liabilities          
Fixed assets and intangible assets book/tax basis difference  $(133,406)  $(129,636)
Right-of-use assets   
-
    (19,248)
Total deferred tax liabilities  $(133,406)  $(148,884)
Net deferred tax assets  $
-
   $
-